Biology of Blood and Marrow Transplantation
Volume 13, Issue 11 , Pages 1358-1368 , November 2007

Status of Donor-Recipient HLA Class I Ligands and Not the KIR Genotype Is Predictive for the Outcome of Unrelated Hematopoietic Stem Cell Transplantation in Beta-Thalassemia Patients

  • Giorgio La Nasa

      Affiliations

    • Cattedra di Ematologia, Centro Trapianti Midollo Osseo, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
    • Corresponding Author InformationCorrespondence and reprint requests: Prof. Giorgio La Nasa, Centro Trapianti Midollo Osseo, Ospedale “R. Binaghi,” ASL No. 8, Via Is Guadazzonis, 3, 09126 Cagliari, Italy.
    • ,
  • Roberto Littera

      Affiliations

    • Centro Regionale Trapianti, Ospedale R. Binaghi-ASL 8, Cagliari, Italy
    • ,
  • Franco Locatelli

      Affiliations

    • Oncoematologia Pediatrica, Università di Pavia, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
    • ,
  • Claudio Giardini

      Affiliations

    • Unità Operativa di Ematologia, Centro Trapianti di Midollo Osseo di Muraglia, Ospedale S. Salvatore, Pesaro, Italy
    • ,
  • Arianna Ventrella

      Affiliations

    • Cattedra di Genetica Medica, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
    • ,
  • Marina Mulargia

      Affiliations

    • Cattedra di Genetica Medica, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
    • ,
  • Adriana Vacca

      Affiliations

    • Cattedra di Ematologia, Centro Trapianti Midollo Osseo, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
    • ,
  • Nicola Orrù

      Affiliations

    • Cattedra di Genetica Medica, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
    • ,
  • Sandro Orrù

      Affiliations

    • Cattedra di Genetica Medica, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
    • ,
  • Eugenia Piras

      Affiliations

    • Cattedra di Ematologia, Centro Trapianti Midollo Osseo, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
    • ,
  • Giada Giustolisi

      Affiliations

    • Centro Regionale Trapianti, Ospedale R. Binaghi-ASL 8, Cagliari, Italy
    • ,
  • Daniela Lisini

      Affiliations

    • Oncoematologia Pediatrica, Università di Pavia, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
    • ,
  • Sonia Nesci

      Affiliations

    • Unità Operativa di Ematologia, Centro Trapianti di Midollo Osseo di Muraglia, Ospedale S. Salvatore, Pesaro, Italy
    • ,
  • Giovanni Caocci

      Affiliations

    • Cattedra di Ematologia, Centro Trapianti Midollo Osseo, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy
    • ,
  • Carlo Carcassi

      Affiliations

    • Centro Regionale Trapianti, Ospedale R. Binaghi-ASL 8, Cagliari, Italy
    • Cattedra di Genetica Medica, Ospedale R. Binaghi-ASL 8, Dipartimento di Scienze Mediche Internistiche, Università di Cagliari, Cagliari, Italy

Received 14 March 2007 ,Accepted 20 July 2007.

References 

  1. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity. 2001;15:363–374
  2. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet. 2006;7:277–300
  3. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev. 2001;181:158–169
  4. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol. 2002;20:853–885
  5. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 1995;268:405–408
  6. Marsh SG, Parham P, Dupont B, et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Eur J Immunogenet. 2003;30:229–234
  7. Katz G, Gazit R, Arnon TI, et al. MHC Class-I independent recognition of NK-activating receptor KIR2DS4. J Immunol. 2004;173:1819–1825
  8. Parham P. MHC Class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005;5:201–214
  9. Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94:333–339
  10. De Santis D, Bishara A, Witt CS, et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens. 2005;65:519–528
  11. D’Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1 (A natural killer cell receptor for HLA-B allotypes). J Immunol. 1995;155:2306–2310
  12. Pende D, Biassoni R, Cantoni C, et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med. 1996;184:505–518
  13. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A. Surface NK receptors and their ligands on tumor cells. Semin Immunol. 2006;18:151–158
  14. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med. 1995;181:1133–1144
  15. Hansasuta P, Dong T, Thananchai H, et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol. 2004;34:1673–1679
  16. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA. 1997;94:11520–11525
  17. Khalil-Daher I, Riteau B, Menier C, et al. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol. 1999;43:175–182
  18. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–2100
  19. Davies SM, Ruggieri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood. 2002;100:3825–3827
  20. Ruggeri L, Capanni M, Mancusi A, Martelli MF, Velardi A. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. Transpl Immunol. 2005;14:203–206
  21. Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood. 2003;102:814–819
  22. Farag SS, Bacigalupo A, Eapen M, et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry and the Dutch registry. Biol Blood Marrow Transplant. 2006;12:876–884
  23. Cook MA, Milligan DW, Fegan CD, et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood. 2004;103:1521–1526
  24. Hsu KC, Keever-Taylor CA, Wilton A, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005;105:4878–4884
  25. Beelen DW, Ottinger HD, Ferencik S, et al. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood. 2005;105:2594–2600
  26. Lucarelli G, Giardini C, Angelucci E. Bone marrow transplantation in thalassemia. In:  Winter JN editors. Blood Stem Cell Transplantation. Boston, MA: Kluwer Academic; 1997;p. 305–315
  27. La Nasa G, Argiolu F, Giardini C, et al. Unrelated bone marrow transplantation for β-thalassemia patients (The experience of the Italian Bone Marrow Transplant Group). Ann N Y Acad Sci. 2005;1054:186–195
  28. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295–304
  29. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation (second of two parts). N Engl J Med. 1975;292:895–902
  30. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood. 2004;103:1417–1424
  31. Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood. 2006;107:2984–2992
  32. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics. 2002;54:221–229
  33. Gagne K, Brizard G, Gueglio B, et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol. 2002;63:271–280
  34. Kaplan ER, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457
  35. Klein JP, Rizzo JD, Zhang M-J, Keiding N. Statistical methods for analysis and presentation of the results of bone marrow transplants, part I: unadjusted analysis. Bone Marrow Transplant. 2001;28:909–915
  36. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706
  37. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187–220
  38. Klein JP, Rizzo JD, Zhang M-J, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants, part 2: regression modeling. Bone Marrow Transplant. 2001;28:1001–1011
  39. Bontadini A, Testi M, Cuccia M, et al. Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population. J Transl Med. 2006;4:44
  40. Shanmugaapriya S, Vikram M, Kavitha ML, et al. Effect of KIR genotype on outcome of related HLA identical stem cell transplant in patients with β thalassaemia major. Blood. 2004;104
  41. Murphy WJ, Koh CY, Raziuddin A, Bennett M, Longo DL. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev. 2001;181:279–289
  42. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol. 1996;156:3098–3101
  43. Pende D, Biassoni R, Cantoni C, et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med. 1996;184:505–518

PII: S1083-8791(07)00369-2

doi: 10.1016/j.bbmt.2007.07.011

Biology of Blood and Marrow Transplantation
Volume 13, Issue 11 , Pages 1358-1368 , November 2007

Article Tools

* Image Usage & Resolution